Moreover, the involvement of the PI3K/AKT signaling pathway further elucidates the molecular complexity underpinning the translational effects promoted by SPDEF through S100A16. These findings shed light on potential therapeutic options and highlight the importance of further investigating these molecular dynamics for effective intervention in PAAD. This evidence concerns the gene AKT1 and pancreatic adenocarcinoma.